CD8A and myeloid sarcoma: In human MS, we have shown that exacerbation is associated with the lack of CD8 T cell regulatory function, which is restored in the quiescence phase of MS13, suggesting that maintenance of CD8 T cell regulatory function through transfer of autologous CD8 T cells may be an effective way of preventing relapses in MS.